Tenon Medical Inc. (TNON) is a Medical/Dental Instruments company listed on NASDAQ. In the last 30 days Quantisnow tracked 8 wire items for TNON, including 4 SEC filings, 3 market updates and 1 insider trade. The most recent was published Oct 29, 2026.
TNON rankings
Financial highlights
Full financials- Revenue, TTM
- $5.31M
- Revenue growth
- +80.3%
- Net income, TTM
- -$13.70M
- Net margin
- -257.9%
- Free cash flow, TTM
- -$12.30M
- Cash
- $1.68M
For the twelve months ended Jun 30, 2026, from SEC filings. Not investment advice.
News · 26 weeks790%
2026-05-102026-11-01
Mix4590d
- SEC Filings18(40%)
- Market11(24%)
- Insider8(18%)
- Offering5(11%)
- Other3(7%)
Latest news
25 items- NEWSTenon Medical, Inc. Sets Date for Third Quarter 2026 EarningsLOS GATOS, CA / ACCESS Newswire / October 29, 2026 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company redefining care for patients with sacro-pelvic disorders, today announced plans to release financial results for the third quarter ended September 30, 2026 after market close on Thursday, November 12, 2026. The Company will also hold a conference call on the same day at 4:30 p.m. Eastern Time to discuss its financial results in further detail. The call will conclude with a Q&A session with its covering analysts.Date:Thursday, November 12, 2026Time:4:30 p.m. Eastern timeDial-in:1-877-407-0792International Dial-in:1-201-689-8263Webcast:TNON Conference Call Please dial in
- NEWSTenon Medical(R) Announces Completion of Initial Alpha Cases of the New Quickstep(TM) Decorticator for the Next-Generation SImmetry(R)+ SI Joint Fusion System~ New decortication system is the latest advancement in Tenon's next-generation SI joint fusion platform with additional innovative product launches expected in the coming quarters ~~ Quickstep Decorticator designed to streamline joint decortication and simplify the SImmetry+ surgical workflow ~~ Full market release of Quickstep targeted for the first quarter of 2027. Company believes Quickstep will further support long-term adoption of the SImmetry+ System ~ LOS GATOS, CA / ACCESS Newswire / October 28, 2026 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company redefining care for patients with sacro-pelvic disorders, today announced the completion of the initial a
- SECSEC Form 8-K filed by Tenon Medical Inc.8-K - Tenon Medical, Inc. (0001560293) (Filer)
- SECSEC Form 424B5 filed by Tenon Medical Inc.424B5 - Tenon Medical, Inc. (0001560293) (Filer)
- NEWSTenon Medical(R) Adds Eight New Patents Issued by the United States Patent and Trademark Office Through Q3 2026~Newly issued patents continue to solidify the company's position as an innovator in the rapidly growing sacro-pelvic fusion market~~Portfolio now includes 38 issued U.S. patents and 9 international patents, with 31 applications pending~~Company anticipates continued additions to its IP portfolio along with several product launches in the coming quarters~ LOS GATOS, CA / ACCESS Newswire / October 15, 2026 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a medical device company dedicated to transforming care for patients suffering from certain sacro-pelvic disorders, today announced that the U.S. Patent and Trademark Office (USPTO) has issued 8 new patents to the Company
- SECSEC Form EFFECT filed by Tenon Medical Inc.EFFECT - Tenon Medical, Inc. (0001560293) (Filer)
- SECSEC Form 424B3 filed by Tenon Medical Inc.424B3 - Tenon Medical, Inc. (0001560293) (Filer)
- INSIDERSEC Form 3 filed by Tenon Medical Inc.3 - Tenon Medical, Inc. (0001560293) (Issuer)
- NEWSTenon(R) Medical Announces Full Commercial Launch of the SImmetry(R)+ SI Joint Fusion 3D Printed Lateral Screw Following Successful Alpha Launch~ SImmetry+ System generated approximately $1.2 million in incremental revenue during limited launch period ~~ Company plans to support anticipated demand for the SImmetry+ System by expanding its instrument set inventory as needed ~~ New SImmetry+ 3D printed screw is the first component of a next-generation lateral SI joint fusion system, and the first of several Company product launches expected in the coming quarters ~ LOS GATOS, CA / ACCESS Newswire / September 30, 2026 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company redefining care for patients with sacro-pelvic disorders, today announced the full commercial launch of its new titanium 3D- printed lateral
- SECTenon Medical Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and Exhibits8-K - Tenon Medical, Inc. (0001560293) (Filer)
- PRWallachBeth Capital Announces Closing of Tenon Medical Warrant Inducement Offering for Aggregate Gross Proceeds of Approximately $2,872,338JERSEY CITY, N.J., Sept. 14, 2026 /PRNewswire/ -- WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announced today that Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a medical device company dedicated to transforming care for patients with certain sacro-pelvic disorders has closed its previously announced warrant inducement agreement with an institutional investor to exercise outstanding warrants to purchase an aggregate of 572,179 of the Company's shares of common stock (the "Existing Warrants"). In consideration for the immediate exercise in full of the Existing Warrants for gross cash proceeds of $2,872,338.58, the exerci
- NEWSTenon Medical Announces Closing of Warrant Inducement Offering for Aggregate Gross Proceeds of Approximately $2,872,338LOS GATOS, CA / ACCESS Newswire / September 14, 2026 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a medical device company dedicated to transforming care for patients with certain sacro-pelvic disorders, announced today it has closed its previously announced warrant inducement agreement with an institutional investor to exercise outstanding warrants to purchase an aggregate of 572,179 of the Company's shares of common stock (the "Existing Warrants").In consideration for the immediate exercise in full of the Existing Warrants for gross cash proceeds of $2,872,338.58, the exercising holder received new unregistered warrants (the "New Warrants") to purchase up to an aggregate
- INSIDERLarge owner Hrt Financial Lp bought $382,985 worth of shares (108,140 units at $3.54) and sold $538,645 worth of shares (125,925 units at $4.28), increasing direct ownership by 714% to 15,839 units (SEC Form 4)4 - Tenon Medical, Inc. (0001560293) (Issuer)
- PRWallachBeth Capital Announces Tenon Medical Warrant Inducement for Gross Proceeds of Approximately $2,872,338JERSEY CITY, N.J., Sept. 11, 2026 /PRNewswire/ -- WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announced today that Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a medical device company dedicated to transforming care for patients with certain sacro-pelvic disorders has entered into warrant exercise agreements with an institutional investor to exercise outstanding warrants to purchase an aggregate of 572,179 of the Company's shares of common stock (the "Existing Warrants"). In consideration for the immediate exercise in full of the Existing Warrants for gross cash proceeds of $2,872,338.58, the exercising holder will rec
- NEWSTenon Medical Announces Warrant Inducement for Aggregate Gross Proceeds of Approximately $2,872,338LOS GATOS, CA / ACCESS Newswire / September 11, 2026 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a medical device company dedicated to transforming care for patients with certain sacro-pelvic disorders announced today it has entered into warrant exercise agreements with an institutional investor to exercise outstanding warrants to purchase an aggregate of 572,179 of the Company's shares of common stock (the "Existing Warrants"). In consideration for the immediate exercise in full of the Existing Warrants for gross cash proceeds of $2,872,338.58, the exercising holders will receive in a private placement new unregistered warrants (the "New Warrants") to purchase up to an a
- INSIDERChief Financial Officer Williamson Kevin converted options into 30 shares and covered exercise/tax liability with 11 shares, increasing direct ownership by 0.74% to 2,580 units (SEC Form 4)4 - Tenon Medical, Inc. (0001560293) (Issuer)
- PRBig Pharma Setbacks Create a New Wave of Rebound PlaysDENVER, Sept. 10, 2026 (GLOBE NEWSWIRE) -- The biotech tape delivered a brutal reminder of one of the sector’s oldest rules: even a fundamentally strong company can get caught in the crossfire when a major drugmaker suffers a pipeline setback. Yesterday, a setback at Novartis (NYSE:NVS) sent ripples across the biotech space, pressuring companies whose own clinical and corporate announcements remained decidedly positive. The resulting selloff highlighted just how quickly investors can shift from company-specific fundamentals to broader sector risk. For smaller biotech names, that indiscriminate pressure can be painful, but it can also create potentially compelling rebound setups when posit
- PRFour Biotech Stories Heating Up Right NowDENVER, Sept. 09, 2026 (GLOBE NEWSWIRE) -- (247marketnews.com) -- Across different corners of the market, the latest developments are putting investors’ attention back on tangible catalysts: NeOnc Technologies Holdings (NASDAQ:NTHI) is pairing fresh institutional capital with encouraging NEO100 clinical data; Opus Genetics (NASDAQ:IRD) is advancing OPGx-BEST1 toward potential pivotal development after positive early data and FDA feedback; bioAffinity Technologies (NASDAQ:BIAF) removed its Nasdaq compliance overhang while continuing to commercialize CyPath Lung; Tenon Medical (NASDAQ:TNON) eliminated roughly $5.16 million of convertible-note obligations ahead of maturity. NeOnc Raises $15
- SECTenon Medical Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - Tenon Medical, Inc. (0001560293) (Filer)
- NEWSTenon Medical Announces Early Repayment of Its Convertible Notes~ Company Takes Proactive Step to Strengthen Balance Sheet and Maintain Flexibility to Execute on Continued Business Momentum ~ ~ Company Takes Proactive Step to Strengthen Balance Sheet and Maintain Flexibility to Execute on Continued Business Momentum ~ LOS GATOS, CA / ACCESS Newswire / September 9, 2026 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a medical device company dedicated to transforming care for patients with certain sacro-pelvic disorders, today announced that it has repaid in full its outstanding original issue discount senior convertible promissory notes (the "Notes"), which were issued with an aggregate principal balance of approximately $5.16 milli
- INSIDERLarge owner Hrt Financial Lp bought $6,599 worth of shares (1,658 units at $3.98) and sold $5,572 worth of shares (1,506 units at $3.70), increasing direct ownership by 8% to 1,946 units (SEC Form 4)4 - Tenon Medical, Inc. (0001560293) (Issuer)
- SECSEC Form EFFECT filed by Tenon Medical Inc.EFFECT - Tenon Medical, Inc. (0001560293) (Filer)
- SECSEC Form D filed by Tenon Medical Inc.D - Tenon Medical, Inc. (0001560293) (Filer)
- INSIDERLarge owner Hrt Financial Lp bought $8,180 worth of shares (1,790 units at $4.57) and sold $2,038 worth of shares (450 units at $4.53), increasing direct ownership by 295% to 1,794 units (SEC Form 4)4 - Tenon Medical, Inc. (0001560293) (Issuer)
- SECAmendment: SEC Form S-3/A filed by Tenon Medical Inc.S-3/A - Tenon Medical, Inc. (0001560293) (Filer)
TNON FAQ
10 questionsWhat does Tenon Medical Inc. do?
Tenon Medical, Inc., a medical device company, develops surgical implant systems to optimize sacroiliac joint fixation/fusion surgery and corresponding outcomes. It focuses on sells The CATAMARAN SIJ Fusion System that includes instruments and implants designed to prepare and fixate the SI-Joint for fusion in the United States and Puerto Rico. The company was incorporated in 2012 and is based in Los Gatos, California.What is the latest news on TNON?
In the last 30 days Quantisnow tracked 8 wire items for TNON: 4 SEC filings, 3 market updates and 1 insider trade. The most recent was published on October 29, 2026.What is TNON revenue?
Tenon Medical Inc. (TNON) reported $5.31M of revenue for the twelve months ended Jun 30, 2026. That is up 80.3% from the year before. Revenue for fiscal 2025 was $3.94M.Is TNON profitable?
No. Tenon Medical Inc. reported a net loss of $13.70M for the twelve months ended Jun 30, 2026.How much cash and debt does TNON have?
Tenon Medical Inc. reported $1.68M in cash and cash equivalents on its most recent balance sheet in SEC filings.Where does TNON stock trade?
Tenon Medical Inc. (TNON) is listed on NASDAQ.What sector and industry is TNON in?
Tenon Medical Inc. operates in the Health Care sector, Medical/Dental Instruments industry.When did Tenon Medical Inc. go public?
Tenon Medical Inc. (TNON) completed its IPO in 2022.What companies are similar to TNON?
Notable peers in the same industry include SYK (Stryker Corporation), MMM (3M Company), BSX (Boston Scientific Corporation), BDX (Becton Dickinson and Company), MDLN (Medline Inc.). Compare TNON side-by-side with any of them on Quantisnow.How can I track TNON on Quantisnow?
Quantisnow aggregates Tenon Medical Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow TNON to receive live email and push alerts on every new disclosure.